Dr. Sudhakar Narhar Chandurkar, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 25200 Center Ridge Rd, Suite 260, Westlake, OH 44145 Phone: 440-331-4816 Fax: 440-331-3790 |
Atul R Hulyalkar, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 29101 Health Campus Dr Bldg 2, Westlake, OH 44145 Phone: 440-250-1806 Fax: 440-835-4788 |
James R Crandell, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 25200 Center Ridge Rd Ste 1100, Westlake, OH 44145 Phone: 440-331-4853 Fax: 440-333-7044 |
Dr. Lori A Rusterholtz, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 29325 Health Campus Dr, Suite 3, Westlake, OH 44145 Phone: 440-414-9400 Fax: 216-201-5591 |
Nadim Al-mubarak, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 29101 Health Campus Dr Bldg 2, Westlake, OH 44145 Phone: 440-835-8922 Fax: 440-835-4788 |
Harry Persaud, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 29099 Health Campus Drive, Suite 110 Bldg #3, Westlake, OH 44145 Phone: 440-835-6169 Fax: 440-892-6514 |
Umbreen Azmat Hussain, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 29099 Health Campus Dr Ste 150, Westlake, OH 44145 Phone: 440-925-7000 Fax: 440-925-7001 |
News Archive
A breakthrough using cutting-edge stem cell research could speed up the discovery of new treatments for motor neurone disease (MND).
Scientists from the Burnham Institute for Medical Research and the University of Vermont have captured the first 3-dimensional (3D) atomic-resolution images of the motor protein myosin V as it "walks" along other proteins, revealing new structural insights that advance the current model of protein motility and muscle contraction.
The concept of fast track rehabilitation program has been recently introduced in colorectal surgery. It is basically a multidisciplinary perioperative care strategy for patients after resection of colorectal cancer.
Pfizer, the largest drug maker in the world, disclosed 35 million in payments during the second half of 2009 to doctors who consulted or spoke on behalf of drugs and to the medical centers that tested them, The New York Times reports. This is Pfizer's first disclosure of this nature. "While other pharmaceutical companies have disclosed payments to doctors, Pfizer is the first to disclose payments for the clinical trials. The disclosure does not include payments outside the United States" (Wilson, 3/31).
In a post in the Center for Global Health Policy's "Science Speaks" blog, Lucica Ditiu, executive secretary of the Stop TB Partnership, examines the need to include tuberculosis (TB) in the global AIDS response blueprint that Secretary of State Hillary Clinton announced at the XIX International AIDS Conference.
› Verified 3 days ago